共 50 条
- [31] INFLUENCE OF DRUG-DOSAGE IN COMBINATION THERAPY DURING REMISSION IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 80 - 80
- [34] DECREASE OF CEREBRAL GLUCOSE-METABOLISM IN PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA AFTER HIGH-DOSE METHOTREXATE THERAPY BRAIN & DEVELOPMENT, 1987, 9 (02): : 213 - 213
- [36] L-ASPARAGINASE AS A SINGLE AGENT IN ACUTE LYMPHOCYTIC-LEUKEMIA - SURVEY OF STUDIES FROM CHILDRENS CANCER STUDY-GROUP CANCER TREATMENT REPORTS, 1981, 65 : 101 - 107
- [37] PROLONGED 2ND REMISSIONS IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - A REPORT FROM THE CHILDRENS-CANCER-STUDY-GROUP MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (01): : 1 - 7
- [39] HIGH-DOSE INTRAVENOUS (IV) METHOTREXATE (MTX) WITH AN INTRATHECAL (IT) MTX BOOST IN THE MAINTENANCE OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) IN CHILDREN - A PILOT-STUDY PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 389 - 389
- [40] CENTRAL NERVOUS-SYSTEM (CNS) STATUS 5 YEARS AFTER PREVENTIVE CNS THERAPY FOR CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA (ALL) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 98 - 98